Novartis Eyes Fourth Approval For Cosentyx

An nr-axSpA okay will boost Swiss major's biggest seller

 
• By Kevin Grogan
  
Four
Cosentyx could soon be approved for four indications • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category